Taro Pharmaceutical Industries Ltd.
(NYSE : TARO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. 0.28%137.581.9%$234.52m
MYLMylan NV 1.11%15.933.2%$108.53m
TEVATeva Pharmaceutical Industries Ltd. -1.43%11.352.0%$107.79m
BBIOBridgeBio Pharma, Inc. -1.91%29.760.0%$27.36m
RDYDr. Reddy's Laboratories Ltd. 1.10%52.882.0%$10.36m
COCPCocrystal Pharma, Inc. 4.08%1.530.0%$8.63m
TXMDTherapeuticsMD, Inc. 6.92%1.3922.1%$7.91m
ABEOAbeona Therapeutics, Inc. 0.00%2.854.5%$2.57m
TAROTaro Pharmaceutical Industries Ltd. -0.19%67.366.5%$2.40m
KINKindred Biosciences, Inc. -7.74%4.170.3%$2.22m
CPHIChina Pharma Holdings, Inc. -3.15%0.600.1%$2.04m
JAGXJaguar Health, Inc. -1.19%0.481.7%$1.75m
LFVNLifeVantage Corp. 4.12%14.143.3%$1.35m

Company Profile

Taro Pharmaceutical Industries Ltd. is engaged in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.